TapewireFind a company

person · Reporting owner

Okupe Oluyemi

Disclosed activity across 1 company

Tapewire entity
21133
SEC CIK
0001907056

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Chief Financial OfficerOctober 01, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date October 01, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect234,527 Reported balance After 2026-10-01 transaction · row 1
1 source row

Row 1 · 2026-10-01 · Sale · Disposed 2,000 · Balance 234,527

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 207,814 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · derivative · entry 11

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 620,033

Underlying: Class A Common Stock · 207,814 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F9 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 11,700 $0.00 Strike: $11.53 $0.00
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · derivative · entry 10

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,832

Underlying: Class A Common Stock · 11,700 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F8 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 16,400 $21.07 $345,546.36
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 9

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,763

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.00 - $21.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 183,600 $20.37 $3,739,050.72
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 8

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,163

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.045 - $20.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 11,700 $20.04 $234,415.35
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 7

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 345,763

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.02 - $20.045. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 40,132 $19.98 $801,849.40
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 357,463

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95 - $20.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,326 $19.95 $126,203.70
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 397,595

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,193 $19.95 $183,394.83
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 403,921

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.82 - $20.015 The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,388 $20.00 $47,768.36
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 413,114

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 207,814 $5.01 $1,041,148.14
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 415,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
October 14, 2024 Filed Oct 16, 2024 21:49 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 11,700 $11.53 $134,901.00
Disclosure

SEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 207,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 20:21 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,868 $19.96 $196,991.92
Disclosure

SEC source: 0001773751-24-000315 · wk-form4_1728418867.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 195,988

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95 - $19.985. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 20:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,437 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 827,847

Underlying: Class A Common Stock · 6,437 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 20:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 997 $19.08 $19,024.26
Disclosure

SEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,856

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.02 - $19.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 20:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,391 $19.04 $26,482.55
Disclosure

SEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,853

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.93 - $19.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 20:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,193 $18.88 $173,577.63
Disclosure

SEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 208,244

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.77 - $19.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 20:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,437 $5.01 $32,249.37
Disclosure

SEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
September 20, 2024 Filed Sep 23, 2024 20:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 12,651 $16.79 $212,355.89
Disclosure

SEC source: 0001773751-24-000306 · wk-form4_1727123745.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,000

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.72 - $16.84. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 13, 2024 Filed Sep 17, 2024 23:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 22,988 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,833

Underlying: Class A Common Stock · 22,988 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
September 13, 2024 Filed Sep 17, 2024 23:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,335 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,344

Underlying: Class A Common Stock · 18,335 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.

Read SEC document
September 13, 2024 Filed Sep 17, 2024 23:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 52,395 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · derivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,372

Underlying: Class A Common Stock · 52,395 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").

Read SEC document
September 13, 2024 Filed Sep 17, 2024 23:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 51,536 $16.57 $853,951.52
Disclosure

SEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,651

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
September 13, 2024 Filed Sep 17, 2024 23:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 93,718 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,187

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 22:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 9,199 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · derivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 834,284

Underlying: Class A Common Stock · 9,199 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 22:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,399 $14.58 $20,403.02
Disclosure

SEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 181,469

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.55 - $14.64. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 22:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,008 $14.59 $14,703.29
Disclosure

SEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 182,868

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.55 - $14.64. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 22:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3 $14.60 $43.80
Disclosure

SEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 183,876

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 22:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,199 $14.60 $134,328.40
Disclosure

SEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 183,879

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.55 - $14.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 22:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 9,199 $5.01 $46,086.99
Disclosure

SEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 193,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
August 13, 2024 Filed Aug 14, 2024 20:15 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,430 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000272 · wk-form4_1723666546.xml · derivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 843,483

Underlying: Class A Common Stock · 6,430 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
August 13, 2024 Filed Aug 14, 2024 20:15 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,430 $5.01 $32,214.30
Disclosure

SEC source: 0001773751-24-000272 · wk-form4_1723666546.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 01:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 11,546 $22.21 $256,489.77
Disclosure

SEC source: 0001773751-24-000213 · wk-form4_1719364942.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,449

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $22.16 - $22.285. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:26 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 22,988 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,821

Underlying: Class A Common Stock · 22,988 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:26 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,334 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,679

Underlying: Class A Common Stock · 18,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:26 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 52,395 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · derivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,767

Underlying: Class A Common Stock · 52,395 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:26 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 51,561 $23.75 $1,224,573.75
Disclosure

SEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,995

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:26 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 93,717 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,556

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:36 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 7,396 $0.00 Strike: $11.53 $0.00
Disclosure

SEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,532

Underlying: Class A Common Stock · 7,396 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F4 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:36 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 86,398 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 849,913

Underlying: Class A Common Stock · 86,398 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:36 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 98,635 $21.42 $2,113,225.28
Disclosure

SEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,839

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F2 · balance_after: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.14 - $21.725. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:36 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 7,396 $11.53 $85,275.88
Disclosure

SEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 245,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:36 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 86,398 $5.01 $432,853.98
Disclosure

SEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 28,084 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · derivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 936,311

Underlying: Class A Common Stock · 28,084 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F7 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,349 $17.95 $60,120.24
Disclosure

SEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,680

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.86 - $18.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,349 $17.97 $60,190.91
Disclosure

SEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,029

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.88 - $18.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 31,433 $17.86 $561,377.66
Disclosure

SEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 158,378

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.63 - $18.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 28,084 $5.01 $140,700.84
Disclosure

SEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,900 $20.01 $138,043.47
Disclosure

SEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 161,727

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 20, 2024 Filed Mar 21, 2024 23:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,304 $15.83 $52,294.06
Disclosure

SEC source: 0001773751-24-000088 · wk-form4_1711062467.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,627

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.76 - $15.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 20, 2024 Filed Mar 21, 2024 23:07 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,304 $15.82 $52,261.68
Disclosure

SEC source: 0001773751-24-000088 · wk-form4_1711062467.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,931

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.76 - $15.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.